Registry for Endovascular Thrombectomy in Acute Ischemic Stroke in Taiwan
Taiwan Registry of Endovascular Thrombectomy for Acute Ischemic Stroke
This study collects information from patients in Taiwan who have had a stroke and received a specific treatment called endovascular thrombectomy to see how well it works and how safe it is.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05281055 on ClinicalTrials.gov |
What this trial studies
This registry collects data from multiple centers in Taiwan on patients with acute ischemic stroke who undergo endovascular thrombectomy (EVT). It began in January 2019 and includes demographic information, medical history, stroke onset timing, severity, treatment details, and outcomes at three months post-stroke. The aim is to evaluate the efficacy and safety of EVT in the Taiwanese population, particularly given the lack of diversity in previous studies. The registry also incorporates standardized imaging analysis to quantify de-identified imaging data.
Who should consider this trial
Good fit: Ideal candidates are individuals with acute ischemic stroke caused by large vessel occlusion who can be treated within 24 hours of onset.
Not a fit: Patients with strokes caused by intracranial hemorrhage or those who do not undergo endovascular thrombectomy will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of EVT outcomes in diverse populations and improve treatment protocols for acute ischemic stroke.
How similar studies have performed: Previous studies on endovascular thrombectomy have shown significant success, but this registry aims to address gaps in knowledge regarding racial differences in treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute ischemic stroke caused by intracranial large vessel occlusion * Can be treated within 24 hours of stroke onset. * Large vessel occlusion demonstrated by magnetic resonance imaging angiography (MRA), computed tomography angiography (CTA) or digital substraction angiography (DSA). * Pre-stroke independence (modified Rankin Scale 0-2). Exclusion Criteria: * Other cause of stroke, such as intracranial hemorrhage. * Not underwent endovascular thrombectomy
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Sung-Chun Tang, MD, PhD — National Taiwan University Hospital
- Study coordinator: Sung-Chun Tang, MD, PhD
- Email: sctang@ntuh.gov.tw
- Phone: 886223123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.